EGFR and hepatocellular carcinoma: We recently showed that EGFR is decorated with mucin-type O-glycans, and the O-glycans and activity of EGFR can be modified by N-acetylgalactosaminyltransferase 2 (GALNT2) in hepatocellular carcinoma [27].